IL10 and myocardial infarction: By identifying an optimal range of IL-10 doses for cardiac repair via intramyocardial administration, we believe it is possible to safely utilize IL-10 to facilitate myocardial recovery post-MI, prevent adverse effects from IL-10 overdose, and lower the total cost of the costly recombinant protein treatment.